301 related articles for article (PubMed ID: 18234905)
1. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM
Thorax; 2008 May; 63(5):415-22. PubMed ID: 18234905
[TBL] [Abstract][Full Text] [Related]
2. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials.
Kyriakidou KG; Rafailidis P; Matthaiou DK; Athanasiou S; Falagas ME
Clin Ther; 2008 Oct; 30(10):1859-68. PubMed ID: 19014841
[TBL] [Abstract][Full Text] [Related]
3. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
5. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
6. Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis.
Falagas ME; Avgeri SG; Matthaiou DK; Dimopoulos G; Siempos II
J Antimicrob Chemother; 2008 Sep; 62(3):442-50. PubMed ID: 18467303
[TBL] [Abstract][Full Text] [Related]
7. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
Solèr M; Mütterlein R; Cozma G;
Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
[TBL] [Abstract][Full Text] [Related]
8. Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?
Bont J; Hak E; Birkhoff CE; Hoes AW; Verheij TJ
Fam Pract; 2007 Sep; 24(4):317-22. PubMed ID: 17602175
[TBL] [Abstract][Full Text] [Related]
9. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
10. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD.
Anzueto A; Miravitlles M
Respir Med; 2010 Oct; 104(10):1396-403. PubMed ID: 20580215
[TBL] [Abstract][Full Text] [Related]
11. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
[TBL] [Abstract][Full Text] [Related]
12. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.
Miravitlles M; Anzueto A; Ewig S; Legnani D; Stauch K
Ther Adv Respir Dis; 2009 Dec; 3(6):267-77. PubMed ID: 19880426
[TBL] [Abstract][Full Text] [Related]
14. Development of a COPD severity score.
Wu EQ; Birnbaum HG; Cifaldi M; Kang Y; Mallet D; Colice G
Curr Med Res Opin; 2006 Sep; 22(9):1679-87. PubMed ID: 16968571
[TBL] [Abstract][Full Text] [Related]
15. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.
Wilson R; Jones P; Schaberg T; Arvis P; Duprat-Lomon I; Sagnier PP;
Thorax; 2006 Apr; 61(4):337-42. PubMed ID: 16449273
[TBL] [Abstract][Full Text] [Related]
17. Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.
Aaron SD; Fergusson D; Marks GB; Suissa S; Vandemheen KL; Doucette S; Maltais F; Bourbeau JF; Goldstein RS; Balter M; O'Donnell D; Fitzgerald M;
Thorax; 2008 Feb; 63(2):122-8. PubMed ID: 17702790
[TBL] [Abstract][Full Text] [Related]
18. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
19. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
Petitpretz P; Choné C; Trémolières F;
Int J Antimicrob Agents; 2007 Jul; 30(1):52-9. PubMed ID: 17512704
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.
Li JZ; Winston LG; Moore DH; Bent S
Am J Med; 2007 Sep; 120(9):783-90. PubMed ID: 17765048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
